speaker-icon

Latest Posts

Partex-NV-announces-collaboration-with-Althea-DRF-Lifesciences

28

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More
Partex-Group-presents-results-from-a-pilot-project-with-AIO

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Archives: News

why-pharma-companies

Why pharma companies need to upgrade their intelligence Pharmaphorum

In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive edge in this rapidly–changing world. As the Nobel-prize-winning economist Daniel Kahneman wrote in his book Thinking, Fast and Slow, “Intelligence is not only the ability to reason; it is also the ability to find relevant …

Why pharma companies need to upgrade their intelligence Pharmaphorum Read More »

artificial-intelligence

How artificial intelligence powers healthcare innovation Digital Commerce 360

When medicine incorporates AI, blockchain, and big data we are going to lower costs, reduce health disparity, and speed novel therapeutics to market.     As Ginny Rometti, the current CEO of IBM and also the first woman to head the company is quoted as saying: “Some people call this artificial intelligence, but the reality …

How artificial intelligence powers healthcare innovation Digital Commerce 360 Read More »

solving-big-data-problem

Solving the Big Data problem in pharma innovation Pharmaphorum

The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?  We live in an exciting time for the pharmaceutical industry. Cutting-edge technologies like artificial intelligence (AI) and Blockchain are making headlines or revolutionising everything from drug discovery to …

Solving the Big Data problem in pharma innovation Pharmaphorum Read More »

machine-learning

Using AI & Machine Learning, Indo-German company Innoplexus is helping reduce the time it takes for medicines to reach patients

Making more people aware about clinical trials that identify data patterns on usage of a particular drug to discover if it can be repurposed and used for faster treatment of serious terminal illnesses. This is just one of the ways in which Innoplexus is harnessing the enormous power of data using Artificial Intelligence (AI), Machine Learning (ML) …

Using AI & Machine Learning, Indo-German company Innoplexus is helping reduce the time it takes for medicines to reach patients Read More »

aI-blockchain

How AI, blockchain, and big data can reduce drug development costs Pharmaphorum

Cutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. It’s no secret that drug prices are a controversial issue. Just last week, US President Trump called high drug prices an “injustice” and vowed to make the issue a priority for his administration. In the …

How AI, blockchain, and big data can reduce drug development costs Pharmaphorum Read More »

innoplexus-strengthens-leadership-team

Innoplexus strengthens its global leadership team with accomplished leaders- appoints Silke Otte as Chief Marketing Officer and Graeme Mcfarlane as the Chief Commercial Officer

Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team. Lawrence is widely respected as exceptional team builder and accomplished leader in Pharma Industry. His addition to leadership team …

Innoplexus strengthens its global leadership team with accomplished leaders- appoints Silke Otte as Chief Marketing Officer and Graeme Mcfarlane as the Chief Commercial Officer Read More »

lawrence-ganti

Gaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence Ganti joins Innoplexus as CEO, Americas

Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today appointment of Lawrence Ganti as Chief Executive Officer of Innoplexus, Americas, further strengthening its leadership team. Lawrence is widely respected as exceptional team builder and accomplished leader in Pharma Industry. His addition to leadership team …

Gaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence Ganti joins Innoplexus as CEO, Americas Read More »